WILMINGTON, DE / ACCESSWIRE / June 23, 2023 / The global radiation proctitis market is estimated to expand at a CAGR of ~7% during the forecast period from 2020 to ...
NEW YORK, NY --(Marketwired - April 29, 2015) - The following is a statement issued by Expert Jeffrey Davis, COO, PlasmaTech Biopharmaceuticals (PTBI): Radiation Proctitis ("RP") is a term used to ...
The management of radiation proctitis and related complications remains a significant clinical challenge, given the complex interplay between acute mucosal injury and chronic inflammatory processes ...
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that it has advanced development of a new proprietary product, called ProctiGard™, for the treatment of radiation proctitis. Radiation proctitis ...
Transitional cell carcinomas of the upper urothelial tract: A retrospective analysis No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual ...
Radiation telangiectasias are part of the spectrum of mucosal changes seen in radiation proctitis following treatment of prostate carcinoma and other intrapelvic neoplasias. Due to its fixed location, ...
March 29, 2011 (Vienna, Austria) — Insertion of ProSpace (Bioprotect), a biodegradable, inflatable balloon system, between prostate and rectum has been shown to reduce the volume of rectum exposed to ...
A randomized study of a patient narrative (storytelling) medical education process for third year medical students compared to standard clinical experience in an academic oncology practice No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results